Compare PRAX & SSD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRAX | SSD |
|---|---|---|
| Founded | 2015 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 8.3B |
| IPO Year | 2020 | 1996 |
| Metric | PRAX | SSD |
|---|---|---|
| Price | $308.01 | $181.88 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 2 |
| Target Price | ★ $572.13 | $206.00 |
| AVG Volume (30 Days) | ★ 331.9K | 221.6K |
| Earning Date | 05-12-2026 | 05-12-2026 |
| Dividend Yield | N/A | ★ 0.62% |
| EPS Growth | N/A | ★ 8.42 |
| EPS | N/A | ★ 8.24 |
| Revenue | N/A | ★ $2,332,808,000.00 |
| Revenue This Year | N/A | $3.82 |
| Revenue Next Year | $6,395.88 | $5.57 |
| P/E Ratio | ★ N/A | $22.59 |
| Revenue Growth | N/A | ★ 4.51 |
| 52 Week Low | $26.70 | $137.35 |
| 52 Week High | $354.87 | $211.98 |
| Indicator | PRAX | SSD |
|---|---|---|
| Relative Strength Index (RSI) | 43.37 | 35.85 |
| Support Level | $290.36 | $163.95 |
| Resistance Level | $322.32 | $187.60 |
| Average True Range (ATR) | 19.36 | 5.04 |
| MACD | -4.96 | -2.41 |
| Stochastic Oscillator | 26.43 | 4.45 |
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.
Simpson Manufacturing Co Inc is a manufacturer of wood construction products. The company offers connectors, truss plates, fastening systems, fasteners, prefabricated lateral systems, concrete construction products, adhesives, mechanical anchors, carbide drill bits, powder-actuated tools, and fiber-reinforced materials. Simpson Manufacturing markets its products to the residential, light industrial, and commercial construction markets as well as the remodeling and do-it-yourself markets. The Company is organized into three reporting segments defined by the regions namely North America, Europe, and Asia Pacific. The company generates the majority of its revenue from wood products.